Results 21 to 30 of about 1,608,385 (286)

Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders. [PDF]

open access: yes, 2008
Antihypertensive drugs are believed to lower blood pressure in pre-eclampsia by direct or central vasodilatory mechanisms. However, they could also act by decreasing production of anti-angiogenic proteins involved in the pathophysiology of hypertension ...
Muttukrishna Shanthi   +11 more
core   +2 more sources

Drug interactions of antihypertensive agents

open access: yesSouth African Family Practice, 2012
No abstract available.
L.H. Opie
doaj   +1 more source

A review of studies of adherence with antihypertensive drugs using prescription databases. [PDF]

open access: yes, 2005
Poor adherence with antihypertensive therapies is a major factor in the low rates of blood pressure control among people with hypertension. Patient adherence is influenced by a large number of interacting factors but their exact impact is not well ...
Fitz-Simon, Nicola   +2 more
core   +1 more source

Antihypertensive Drug Utilization in Two Districts of Northern Cyprus

open access: yesРациональная фармакотерапия в кардиологии, 2019
Aim. Since the irrational use of medicine increases the risk of morbidity and mortality in hypertension, this study was aimed to evaluate antihypertensive pharmacotherapy at two districts of Northern Cyprus (NC).Material and methods.
M. Tamirci, R. Demirdamar
doaj   +1 more source

In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia [PDF]

open access: yes, 2014
Antihypertensive drugs lower the maternal blood pressure in pre-eclampsia (PE) by direct or central vasodilatory mechanisms but little is known about the direct effects of these drugs on placental ...
Muttukrishna, S   +8 more
core   +2 more sources

Achievement rate of blood pressure <140/90 mmHg and <130/80 mmHg in subjects with hypertension; findings from a Japanese health checkup in 2017

open access: yesClinical and Experimental Hypertension, 2020
Blood pressure (BP) control status was investigated using data of a health checkup held in a Japanese city. In fiscal year 2017, 54,287 persons (age, 40–74 years; males, 49%) underwent the checkup; 28,167 examinees had a systolic BP ≥140 mmHg, a ...
Shinichiro Fujishima   +2 more
doaj   +1 more source

Shared Molecular Targets in Parkinson’s Disease and Arterial Hypertension: A Systematic Review

open access: yesBiomedicines, 2022
(1) Background: Parkinson’s disease and arterial hypertension are likely to coexist in the elderly, with possible bidirectional interactions. We aimed to assess the role of antihypertensive agents in PD emergence and/or progression.
Delia Tulbă   +7 more
doaj   +1 more source

Dosing trajectories of antihypertensive agents among preterm neonates: A retrospective, cross-sectional analysis. [PDF]

open access: yesPLoS One
Introduction Preterm infants are at increased risk for hypertension due to incomplete organ development. With no established guidelines for treating hypertension in this population, clinicians rely on their experience, and little is known regarding those
Pittman MC   +7 more
europepmc   +2 more sources

A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?

open access: yesКардиоваскулярная терапия и профилактика, 2011
Angiotensin II receptor blockers (ARBs) have been available in the United Statessince 1995. These agents have demonstrated antihypertensive efficacy at least similar to that of agents from other antihypertensive classes.
M. Greathouse
doaj   +1 more source

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness

open access: yesHepatology, EarlyView., 2022
Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy